Cannabidiol and Epileptic Encephalopathies
To begin the course, please login or register by clicking ENROLL. After logging in, you will be able to complete the pretest and view the video/documents. You will have the option to complete the posttest, evaluation and receive credit. Some courses may have an associated cost.
Starts On:
7/1/2019: 12:00 AM
Ends On:
6/30/2020: 12:00 AM
Session Type:
Internet Activity Enduring Material
Credits:
0.5
Description:
Sleep Fellowship
Disclosures
Financial Relationship: Nothing to disclose
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Pediatric Epilepsy Advanced Technologies and Treatment, August 10, 2018, which was supported in part by The St. Louis Children's Hospital Foundation, Greenwich Biosciences, Inc., Zimmer Biomet, Eisai, Inc., LivaNova USA, Inc. and Nihon Kohden.
Neurosciences Nurse Practitioner, St. Louis Children's Hospital
Financial Relationship: Nothing to disclose
Nausheen Hasan, PharmD, BCPPS
Clinical Pharmacy SpecialistâNeurosciences, St. Louis Children's Hospital
Financial Relationship: Nothing to disclose
Matthew D. Smyth, MD
Disclosures
- Ownership Interest/Stock Equity: Therma Neurosciences
- Consulting/Advisory Committees: Therma Neurosciences
- Licensing/Product Development Agreements or Royalties for inventions/IP: Therma
Neurosciences
Liu Lin Thio, MD, PhD, Course Chair
Disclosure: Consulting/Advisory Committees: Eisai Inc
John Zempel, MD, PhD, Course Chair
Financial Relationship: Nothing to disclose
Faculty
Robert Rudock, MDSleep Fellowship
Disclosures
Financial Relationship: Nothing to disclose
Presenters should indicate if speaking off label. This activity originated as a presentation at the CME activity, Pediatric Epilepsy Advanced Technologies and Treatment, August 10, 2018, which was supported in part by The St. Louis Children's Hospital Foundation, Greenwich Biosciences, Inc., Zimmer Biomet, Eisai, Inc., LivaNova USA, Inc. and Nihon Kohden.
Planning Committee
Tiffany Hammerschmidt, MSN, RN, CPNPNeurosciences Nurse Practitioner, St. Louis Children's Hospital
Financial Relationship: Nothing to disclose
Nausheen Hasan, PharmD, BCPPS
Clinical Pharmacy SpecialistâNeurosciences, St. Louis Children's Hospital
Financial Relationship: Nothing to disclose
Matthew D. Smyth, MD
Disclosures
- Ownership Interest/Stock Equity: Therma Neurosciences
- Consulting/Advisory Committees: Therma Neurosciences
- Licensing/Product Development Agreements or Royalties for inventions/IP: Therma
Neurosciences
Liu Lin Thio, MD, PhD, Course Chair
Disclosure: Consulting/Advisory Committees: Eisai Inc
John Zempel, MD, PhD, Course Chair
Financial Relationship: Nothing to disclose
Objectives:
The intended result of this activity is increased knowledge/competence, and upon completion of this course, participants should be able to:
- Review the history of CBD and what CBD is.
- Identify the limited scientific literature involving CBD and epilepsy.
- Discuss the public perception of CBD.
- Explain current legal issues surrounding CBD.
- Discuss future possible treatments and studies.
Additional Information:
Target Audience: This course is planned and designed inter-professionally by and for physicians, nurses and pharmacists and will focus on the evaluation and treatment of the one third of pediatric epilepsy patients who are not seizure free after treatment with two anti-seizure medications.
Publication Date: July 1, 2019
Expiration Date: June 30, 2020
Target Audience: This course is planned and designed inter-professionally by and for physicians, nurses and pharmacists and will focus on the evaluation and treatment of the one third of pediatric epilepsy patients who are not seizure free after treatment with two anti-seizure medications.
Publication Date: July 1, 2019
Expiration Date: June 30, 2020
Accreditation Information:
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
In support of improving patient care, Washington University School of Medicine in St. Louis is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Awarded for this Activity:
Credit Statement:
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Creditâ˘. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 ANCC contact hours.
American Medical Association (AMA Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 AMA PRA Category 1 Creditâ˘. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
American Nurses Credentialing Center (ANCC Credit)
Washington University School of Medicine in St. Louis designates this enduring material for a maximum of .5 ANCC contact hours.
References:
- D. Friedman, Jj. Sirven / Epilepsy & Behavior 70 (2017) 298-301
- Diabetologia. 2015 Mar;58(3):443-55
- Neuroscience. 2011 Oct 27;194:302-8
- Life Sci. 2014 Feb 27;97(1):78-90
Disclosure Information:
It is the policy of Washington University School of Medicine in St. Louis, Continuing Medical Education, to ensure balance, independence, objectivity and scientific rigor in all its educational activities. All planners, faculty and other persons who may influence content of this CME activity have disclosed all relevant financial relationships with commercial interests. All disclosures have been reported and are indicated with their presentations. Any potential conflicts were addressed and resolved.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
Presenters are also expected to openly disclose inclusion of discussion of any off-label, experimental, or investigational use of drugs or devices in their presentations.
Presentations are expected to be based on evidence that is accepted within the profession of medicine as adequate justification for their indication in the care of patients. All scientific research should conform to the generally accepted standards of experimental design, data collection and analysis. These presentations are not an endorsement of any commercial interests.
These presentations are the views and experiences of the presenters. The presenters' views do not represent the policy or position of Washington University School of Medicine in St. Louis. Washington University School of Medicine in St. Louis, Continuing Medical Education, is the provider for CME credits.
